课题基金 / 基金详情

Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes

Mechanisms of Cellular Senescence Driving Intervertebral Disc Aging through Local Cell Autonomous and Systemic Non-Cell Autonomous Processes
细胞衰老通过局部细胞自主和全身非细胞自主过程驱动椎间盘老化的机制
批准号:
10635092
负责人:
NAM V VO
金额:
$52.69万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-15 至 2028-01-31

项目摘要

项目成果

NAM V VO的其他基金

相关文献

中文摘要
翻译
项目摘要 椎间盘退变(IDD)是许多脊柱疾病的基础,导致背部衰弱 痛苦残疾和巨大的经济损失衰老是碘缺乏病的最大危险因素, 椎间盘老化仍然知之甚少。我们之前的研究表明,持续的DNA损伤会促进 衰老细胞导致其获得衰老相关分泌表型(SASP), 产生大量的炎症和分解代谢因子,促进椎间盘基质丢失,这是椎间盘的普遍特征, 老化和退化。虽然这些发现极大地推进了我们对椎间盘老化的理解, 重要的问题细胞衰老主要是局部、全身还是两者共同驱动椎间盘老化?换句 换句话说,具有组织破坏性SASP的衰老椎间盘细胞是否在细胞自主的 或者来自其他组织的衰老细胞通过内分泌作用系统性地促进椎间盘衰老 通过非细胞自主机制表达SASP和信号因子?此外,这两个 主要的细胞衰老途径,p16 INK 4a或p21 Cip 1,主要驱动局部细胞自主效应 以及系统性非细胞自主作用对椎间盘老化的影响?根据我们的初步数据,我们假设 p21介导的椎间盘细胞衰老的局部效应仅部分导致年龄增长, 依赖性IDD,p16介导的系统性细胞衰老的贡献是必要的, 完全解释了观察到的椎间盘老化表型。我们提出了三个具体目标来测试这一点 假设使用几种创新的转基因小鼠品系:(1)确定局部的相对贡献 (cell自主的)和系统的(非细胞自主的)过程中驱动盘细胞衰老和年龄- (2)确定p21 CIP 1和p16 INK 4a介导的细胞衰老的相对贡献 (3)检测抗衰老治疗是否能延缓年龄依赖性IDD。完成 拟议的研究将确定椎间盘老化主要是由局部还是系统性过程驱动的 以及这些过程是否主要通过p21 Cip 1或p16 INK 4a细胞衰老介导 通路最后,我们提出的研究将确定用于治疗和减缓衰老的新型衰老药物- 依赖IDD。
英文摘要
Project summary Intervertebral disc degeneration (IDD) underlies many spinal disorders resulting in debilitating back pain, disability, and tremendous economic loss. Aging is the greatest risk factor for IDD and yet the biology of disc aging is still poorly understood. Our prior research demonstrated that persistent DNA damage promotes senescent cells resulting in their acquisition of the senescence-associated secretory phenotype (SASP) that produces copious inflammatory and catabolic factors that promote disc matrix loss, a universal feature of disc aging and degeneration. While these findings greatly advance our understanding of disc aging, they also raise important questions. Does cellular senescence mainly drive disc aging locally, systemically, or both? In other words, do senescent disc cells with tissue-destroying SASP locally drive disc aging in a cell-autonomous manner, or do senescent cells from other tissues systemically promote disc aging through the endocrine action of their SASP and signaling factors through non-cell autonomous mechanisms? Moreover, which of the two major cellular senescence pathways, p16INK4a or p21Cip1, predominantly drive the local cell-autonomous effects and the systemic non-cell autonomous effects on disc aging? Based on our preliminary data, we hypothesize that local effects of p21-mediated disc cellular senescence are only partially responsible for driving age dependent IDD, and that contribution from p16-mediated systemic cellular senescence is necessary to fully account for the observed disc aging phenotype. We propose three specific aims to test this hypothesis using several innovative transgenic mouse strains: (1) Determine the relative contributions of local (cell autonomous) and systemic (non-cell autonomous) processes in driving disc cellular senescence and age- dependent IDD; (2) Determine the relative contributions of p21CIP1 and p16INK4a -mediated cellular senescence on age-dependent IDD; and (3) Test whether senolytic treatment can slow age-dependent IDD. Completion of the proposed studies will determine whether disc aging is driven predominantly by local or systemic processes and whether these processes are mediated primarily through the p21Cip1 or p16INK4a cellular senescence pathway. Finally, our proposed studies will identify novel senolytic drugs for treating and slowing age- dependent IDD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
HEALing LB3P: Profiling Biomechanical, Biological and Behavioral phenotypes
The role of cellular senescence in intervertebral disc aging
The role of cellular senescence in intervertebral disc aging